CVS Health Corporation (CVS) Position Maintained by Tufton Capital Management
Tufton Capital Management held its stake in shares of CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,133 shares of the pharmacy operator’s stock at the end of the 2nd quarter. Tufton Capital Management’s holdings in CVS Health Corporation were worth $252,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Mercer Capital Advisers Inc. acquired a new position in CVS Health Corporation in the first quarter valued at approximately $118,000. Gemmer Asset Management LLC boosted its stake in CVS Health Corporation by 15.3% in the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after acquiring an additional 200 shares during the last quarter. TB Alternative Assets Ltd. bought a new position in CVS Health Corporation in the second quarter valued at approximately $121,000. SRS Capital Advisors Inc. boosted its stake in CVS Health Corporation by 48.2% in the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock valued at $177,000 after acquiring an additional 734 shares during the last quarter. Finally, Nadler Financial Group Inc. bought a new position in CVS Health Corporation in the second quarter valued at approximately $202,000. Institutional investors own 81.49% of the company’s stock.
In related news, insider Larry J. Merlo sold 241,150 shares of the business’s stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $83.07, for a total value of $20,032,330.50. Following the completion of the sale, the insider now directly owns 299,255 shares of the company’s stock, valued at approximately $24,859,112.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Thomas M. Moriarty sold 90,267 shares of the company’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $79.61, for a total value of $7,186,155.87. Following the transaction, the executive vice president now directly owns 70,102 shares in the company, valued at $5,580,820.22. The disclosure for this sale can be found here. Insiders have sold a total of 716,625 shares of company stock worth $58,318,431 in the last three months. Insiders own 0.61% of the company’s stock.
A number of analysts have commented on CVS shares. Royal Bank Of Canada started coverage on shares of CVS Health Corporation in a report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 target price for the company. Jefferies Group LLC upped their target price on shares of CVS Health Corporation from $82.00 to $86.00 and gave the company a “hold” rating in a research report on Friday, September 15th. Needham & Company LLC reissued a “hold” rating on shares of CVS Health Corporation in a research note on Sunday, September 10th. BidaskClub downgraded CVS Health Corporation from a “hold” rating to a “sell” rating in a research note on Friday, August 25th. Finally, Loop Capital assumed coverage on CVS Health Corporation in a research report on Thursday, August 24th. They issued a “hold” rating and a $83.00 price target on the stock. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fifteen have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $90.58.
CVS Health Corporation (CVS) opened at 80.91 on Wednesday. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $88.92. The stock’s 50 day moving average price is $79.62 and its 200 day moving average price is $79.03. The firm has a market capitalization of $82.25 billion, a PE ratio of 16.12 and a beta of 0.92.
CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.31 by $0.02. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The firm had revenue of $45.69 billion during the quarter, compared to the consensus estimate of $45.36 billion. During the same period in the previous year, the firm posted $1.32 earnings per share. The business’s revenue was up 4.5% compared to the same quarter last year. On average, analysts predict that CVS Health Corporation will post $5.88 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 3rd. Stockholders of record on Tuesday, October 24th will be given a dividend of $0.50 per share. The ex-dividend date is Monday, October 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.47%. CVS Health Corporation’s dividend payout ratio (DPR) is presently 39.92%.
TRADEMARK VIOLATION WARNING: This piece of content was posted by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/cvs-health-corporation-cvs-position-maintained-by-tufton-capital-management/1606541.html.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.